Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenyu Lin

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Hematological Oncology|May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid LeukemiaGeorgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Nature Communications|March 16, 2024
TANGO6 regulates cell proliferation via COPI vesicle-mediated RPB2 nuclear entryZhi Feng, Shengnan Liu, Ming Su, et al.
Nature Communications|July 9, 2026
Engineered zwitterion-nanodelivery for precision targeting of brain metastasesHaibao Peng, Youming Zeng, Yang Huang, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Communications Biology|August 18, 2021
Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknessesSwetha Rajasekaran, Jalal Siddiqui, Jessica Rakijas, et al.
Transplantation and Cellular Therapy|February 20, 2026
Musculoskeletal Adverse Events Following BCMA CAR-T Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune CorrelatesAmber Feng, Jian Wu, Taewoong Choi, et al.
Transplantation and Cellular Therapy|September 30, 2022
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord BloodChenyu Lin, Gautam Sajeev, Patrick J Stiff, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Bone Marrow Transplantation|April 12, 2025
Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomesMatthew A Bergens, Yen P Lowder, Yan Li, et al.
Transplantation and Cellular Therapy|December 28, 2022
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host DiseaseChenyu Lin, Rachel A DiCioccio, Tarek Haykal, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Hematological Oncology|May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid LeukemiaGeorgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Nature Communications|March 16, 2024
TANGO6 regulates cell proliferation via COPI vesicle-mediated RPB2 nuclear entryZhi Feng, Shengnan Liu, Ming Su, et al.
Nature Communications|July 9, 2026
Engineered zwitterion-nanodelivery for precision targeting of brain metastasesHaibao Peng, Youming Zeng, Yang Huang, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Communications Biology|August 18, 2021
Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknessesSwetha Rajasekaran, Jalal Siddiqui, Jessica Rakijas, et al.
Transplantation and Cellular Therapy|February 20, 2026
Musculoskeletal Adverse Events Following BCMA CAR-T Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune CorrelatesAmber Feng, Jian Wu, Taewoong Choi, et al.
Transplantation and Cellular Therapy|September 30, 2022
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord BloodChenyu Lin, Gautam Sajeev, Patrick J Stiff, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Bone Marrow Transplantation|April 12, 2025
Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomesMatthew A Bergens, Yen P Lowder, Yan Li, et al.
Transplantation and Cellular Therapy|December 28, 2022
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host DiseaseChenyu Lin, Rachel A DiCioccio, Tarek Haykal, et al.
Pageof 9